ArticlePeerJ2022
Applying SARIMA, ETS, and hybrid models for prediction of tuberculosis incidence rate in Taiwan.
Article in PeerJ, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Optimizing Tuberculosis Incidence Prediction: A Systematic Review of Hybrid Modeling Approaches and Machine Learning Techniques.Public health challenges · 2026Review
- A novel time-series modeling framework for predicting tuberculosis incidence in Sichuan, China.BMC infectious diseases · 2026Article
- Temporal trends in tuberculosis incidence among the aging population in Southwest China: a retrospective study.BMC geriatrics · 2026Article
- Tuberculosis incidence and mortality trends in mainland China, 2004-2024: control program and elimination progress.Tropical medicine and health · 2026Article
- Forecasting Tuberculosis Incidence in Somalia: A Comparative Analysis of Single and Hybrid Time-Series Models.Health science reports · 2026Article
- Forecasting Acute Hemorrhagic Conjunctivitis Incidence in Henan, China: A Comparative Study of Seasonal Autoregressive Fractionally Integrated Moving Average and Seasonal Autoregressive Integrated Moving Average Models.Risk management and healthcare policy · 2026Article
- Forecasting tuberculosis epidemics using an autoregressive fractionally integrated moving average model: a 17-year time series analysis.Journal of global health · 2025Article
- Exploring different modelling approaches to forecast the community acute respiratory infections burden in children: an Italian epidemiological time series study.BMC public health · 2025Article
- A hybrid machine learning model for pulmonary tuberculosis forecasting of Chongqing with adjacent-region data.PloS one · 2025Article
- Feasibility of ending tuberculosis in Shangrao City through active intervention measures: a mathematical study.Frontiers in public health · 2025Article
- Time-series analysis for forecasting monthly workload at two elephant hospitals in Thailand.PloS one · 2025Article
- Incidence of acute hemorrhagic conjunctivitis in Chongqing: a forecasting study based on mathematical models.Frontiers in public health · 2025Article
- Trends and multi-model prediction of hepatitis B incidence in Xiamen.Infectious Disease Modelling · 2024Article
- Spatial and temporal analysis and forecasting of TB reported incidence in western China.BMC public health · 2024Article
- Estimating the Temporal Epidemiological Trends of Tuberculosis Incidence by Using an Advanced Theta Method.The American journal of tropical medicine and hygiene · 2024Article
- Prediction of influenza outbreaks in Fuzhou, China: comparative analysis of forecasting models.BMC public health · 2024Article
- Japanese encephalitis transmission trends in Gansu, China: A time series predictive model based on spatial dispersion.One health (Amsterdam, Netherlands) · 2023Article
- A nomogram for predicting mortality of patients initially diagnosed with primary pulmonary tuberculosis in Hunan province, China: a retrospective study.Frontiers in cellular and infection microbiology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tuberculosis (TB) remained one of the world's most deadly chronic communicable diseases. Future TB incidence prediction is a benefit for intervention options and resource-allocation planning. We aimed to develop rapid univariate prediction models for epidemics forecasting employment. Methods: The surveillance data regarding Taiwan monthly TB incidence rates which from January 2005 to June 2017 were utilized for simulation modelling and from July 2017 to December 2020 for model validation. The modeling approaches including the Seasonal Autoregressive Integrated Moving Average (SARIMA), the Exponential Smoothing (ETS), and SARIMA-ETS hybrid algorithms were constructed and compared. The modeling performance of in-sample simulating training sets and pseudo-out-of-sample validating sets were evaluated by metrics of the root mean square error (RMSE), mean absolute percentage error (MAPE), mean absolute error (MAE), and mean absolute scaled error (MASE). Results: A total of 191,526 TB cases with a highest incidence rate in 2005 (72.5 per 100,000 person-year) and lowest in 2020 (33.2 per 100,000 person-year), from January-2005 to December-2020 showed a seasonality and steadily declining trend in Taiwan. The monthly incidence rates data were utilized to formulate these forecasting models. Through stepwise screening and assessing of the accuracy metrics, the optimized SARIMA(3,0,0)(2,1,0) Conclusion: This time series modeling might offer us a rapid surveillance tool for facilitating WHO's future TB elimination milestone. Our proposed SARIMA-ETS or ETS model outperformed the SARIMA in predicting less or 12-30 months ahead of epidemics, and all models showed better in short or medium-term forecasting than long-term forecasting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.